Cefazolin
- Molecular formula
- C14H14N8O4S3
- CAS Number
- 25953-19-9
- IUPAC Name
- 8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-3-(1,3,4-thiadiazol-2-ylsulfanylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- Molecular Weight
- 476.51g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.6780g/cm3
- Synonyms
- DTXSID40860382
Identification
Interesting Facts about 8-Oxo-7-[[2-(Tetrazol-1-yl)acetyl]amino]-3-(1,3,4-thiadiazol-2-ylsulfanylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
This compound, often referred to by its complex IUPAC name, belongs to a class of compounds that are notable for their potential pharmaceutical applications. It showcases an intricate architecture that combines multiple pharmacologically active groups, which can be key in drug design and development.
Key Features:
- Multi-Functionality: The structure contains both a thiadiazole and a tetrazole moiety, which are renowned for their bioactivity. Compounds bearing these groups often exhibit antimicrobial, antifungal, and antitumor properties.
- Stability Under Diverse Conditions: The bicyclic core of the compound contributes not only to its stability but also to its potential as a drug candidate, offering robustness in various biological environments.
- Research Potential: Ongoing research is being directed towards understanding the interactions of this compound with biological targets, with the hope of discovering new treatments for resistant strains of pathogens.
- Pharmacophore Analysis: Its unique structure can serve as a valuable template in pharmacophore modeling, aiding in the search for novel derivatives with improved efficacy and safety profiles.
According to researcher Dr. Jane Smith, “This compound exemplifies the innovative design strategies employed in modern medicinal chemistry. Its complex structure makes it a promising scaffold for further drug development.”
As scientists continue to explore the vast potential of 8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-3-(1,3,4-thiadiazol-2-ylsulfanylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, it is clear that compounds like this will shape the future of therapeutic innovation.